362 related articles for article (PubMed ID: 35043243)
21. UroLift and Rezum: minimally invasive surgical therapies for the management of benign prostatic hyperplasia.
Leong JY; Tokarski AT; Roehrborn CG; Das AK
Can J Urol; 2021 Aug; 28(S2):2-5. PubMed ID: 34453421
[TBL] [Abstract][Full Text] [Related]
22. Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum)
Chin CP; Garden EB; Ravivarapu KT; Shukla D; Omidele O; Levy M; Qian D; Araya JS; Valenzuela R; Reddy A; Marshall S; Motola J; Nobert C; Gupta M; Small AC; Kaplan SA; Palese MA
J Endourol; 2022 Dec; 36(12):1559-1566. PubMed ID: 36039926
[No Abstract] [Full Text] [Related]
23. Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.
Raizenne BL; Zheng X; Oumedjbeur K; Mao J; Zorn KC; Elterman D; Bhojani N; McClure T; Te A; Kaplan S; Sedrakyan A; Chughtai B
World J Urol; 2023 Jan; 41(1):179-188. PubMed ID: 36463348
[TBL] [Abstract][Full Text] [Related]
24. Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.
Hughes T; Harper P; Somani BK
Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895457
[TBL] [Abstract][Full Text] [Related]
25. Aquablation, Prostatic Urethral Lift, and Transurethral Water Vapor Therapy: A Comparison of Device-Related Adverse Events in a National Registry.
Kaplan-Marans E; Martinez M; Wood A; Cochran J; Dubowitch E; Schulman A
J Endourol; 2022 Feb; 36(2):231-235. PubMed ID: 34314240
[No Abstract] [Full Text] [Related]
26. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
[TBL] [Abstract][Full Text] [Related]
27. First- and Second-Generation Temporary Implantable Nitinol Devices As Minimally Invasive Treatments for BPH-Related LUTS: Systematic Review of the Literature.
Amparore D; De Cillis S; Volpi G; Checcucci E; Manfredi M; Morra I; Di Dio M; Fiori C; Porpiglia F;
Curr Urol Rep; 2019 Jul; 20(8):47. PubMed ID: 31278441
[TBL] [Abstract][Full Text] [Related]
28. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
[TBL] [Abstract][Full Text] [Related]
29. Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction.
Sountoulides P; Karatzas A; Gravas S
Ther Adv Urol; 2019; 11():1756287219828971. PubMed ID: 30792821
[TBL] [Abstract][Full Text] [Related]
30. [Office-based therapies for benign prostatic hyperplasia : Update on new minimally invasive surgery therapies].
Baboudjian M; Pradere B
Prog Urol; 2021 Nov; 31(14):931-936. PubMed ID: 34456141
[TBL] [Abstract][Full Text] [Related]
31. Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review.
Gemma L; Pecoraro A; Sebastianelli A; Spatafora P; Sessa F; Nicoletti R; Gravas S; Campi R; Serni S; Gacci M
Prostate Cancer Prostatic Dis; 2024 Feb; ():. PubMed ID: 38355729
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy and safety of prostatic urethral lift vs prostatic artery embolization for benign prostatic hyperplasia: a systematic review and network meta-analysis.
Lucas-Cava V; Sánchez-Margallo FM; Insausti-Gorbea I; Sun F
BJU Int; 2023 Feb; 131(2):139-152. PubMed ID: 35417622
[TBL] [Abstract][Full Text] [Related]
33. Beyond medications: office-based procedures for benign prostatic obstruction.
Tran PU; Chung ASJ
World J Urol; 2019 Jun; 37(6):1023-1027. PubMed ID: 31037402
[TBL] [Abstract][Full Text] [Related]
34. [Minimally invasive treatment of benign prostatic hyperplasia : The German S2e guideline 2023-part 4].
Salem J; Becher KF; Bschleipfer T; Dreikorn K; Höfner K; Madersbacher S; Magistro G; Muschter R; Oelke M; Reich O; Rieken M; Schönburg S; Abt D
Urologie; 2024 Jan; 63(1):58-66. PubMed ID: 38193989
[TBL] [Abstract][Full Text] [Related]
35. Update on minimally invasive surgery and benign prostatic hyperplasia.
Chung ASJ; Woo HH
Asian J Urol; 2018 Jan; 5(1):22-27. PubMed ID: 29379732
[TBL] [Abstract][Full Text] [Related]
36. Temporarily implanted nitinol device versus prostatic urethral lift for minimally invasive surgical treatment of benign prostatic hyperplasia with lower urinary tract symptoms: a matching-adjusted indirect comparison.
Kernen KM; Omar S; Goodnight B; Skodny P; Bruce S; Yu TM
Can J Urol; 2023 Oct; 30(5):11676-11685. PubMed ID: 37838995
[TBL] [Abstract][Full Text] [Related]
37. Comparing prostatic artery embolization to surgical and minimally invasive procedures for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis.
Altman R; Ferreira R; Barragan C; Bhojani N; Lajkosz K; Zorn KC; Chughtai B; Annamalai G; Elterman DS
BMC Urol; 2024 Jan; 24(1):22. PubMed ID: 38281906
[TBL] [Abstract][Full Text] [Related]
38. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
[TBL] [Abstract][Full Text] [Related]
39. New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.
Gupta NK; Gange SN; McVary KT
Sex Med Rev; 2019 Jul; 7(3):491-498. PubMed ID: 29606553
[TBL] [Abstract][Full Text] [Related]
40. [The UroLift® system for treatment of the benign prostatic syndrome (BPS)].
Westhofen T; Magistro G; Stief C; Gratzke C
Aktuelle Urol; 2018 Dec; 49(6):515-518. PubMed ID: 30522162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
